Trial intelligence / Profile preview

Seroquel XR in acute bipolar mania

NCT01128114Phase 4Terminated

Sponsor
AstraZeneca
Start
Jun 2010
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine in bipolar I disorder, sponsored by AstraZeneca. Started Jun 2010; status: terminated.

02

Drugs

quetiapine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT01128114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01128114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call